Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesAug 4, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 2, 2011View HTMLDownload DOCDownload PDF
10-QQuarterly report which provides a continuing view of a company's financial positionAug 1, 2011View HTMLDownload DOCDownload PDFDownload XLSView XBRLDownload XBRL
8-KReport of unscheduled material events or corporate eventJul 28, 2011View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesJul 25, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 25, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 18, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 18, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 18, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 15, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 6, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 6, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 6, 2011View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventJun 23, 2011View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesJun 23, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 9, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 9, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 9, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 9, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 8, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 8, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 2, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 2, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 2, 2011View HTMLDownload DOCDownload PDF
4/AAmendment to a previously filed 4May 31, 2011View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-100      101-115

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information